Overview
- Intuitive Surgical shares rose about 8% Wednesday after Q1 revenue hit $2.77 billion and adjusted EPS reached $2.50, both above forecasts.
- Global procedures grew about 17% as hospitals installed 431 systems, including 232 units of the next‑gen da Vinci 5, which is being used more than the prior Xi model.
- Management raised its 2026 procedure outlook to 13.5%–15.5% and guided gross margin to 67.5%–68.5%, helped by a base that is now 86% consumables and services.
- Product momentum continued, with Ion lung diagnostic procedures up 39% and new FDA clearances expanding uses for Force Feedback instruments.
- The company noted policy and demand pressure in China and parts of Japan and disclosed a Q1 cyber incident with unauthorized data access, while upcoming Japanese reimbursements in June 2026 and a margin plan that accounts for tariffs, freight and memory chips could offset near‑term strain.